• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Saudi Arabia·Healthcare·4017.SR
Share

Dr. Soliman Abdel Kader Fakeeh Stocks

SAR 36.54Last Updated 11.06.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

SAR 2.24B

SAR 36.54
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Dr. Soliman Abdel Kader Fakeeh Hospital Company is a healthcare enterprise dedicated to the development, administration, and operation of hospitals, clinics, as well as medical, educational, and training facilities across the Kingdom of Saudi Arabia. Its extensive range of medical offerings encompasses numerous specialties, including assisted reproductive therapy, audiology, bariatric surgery, a dedicated breast feeding clinic, cardiac surgery, cardiology, chest and respiratory diseases, chiropractic medicine, dental and maxillofacial services, dermatology, otorhinolaryngology (ENT), endocrinology, ophthalmology, family medicine, gastroenterology, general surgery, geriatric medicine, hematology, hyperbaric oxygen services, infectious diseases, internal medicine, interventional radiology, psychiatry, nephrology, neurosurgery, neurology, nutritional services, obstetrics and gynecology, oncology, orthopedics, pain treatment, palliative care, a comprehensive pediatric department (including pediatric surgery), physical medicine and rehabilitation, plastic surgery, rheumatology, a sleep disorders clinic, speech therapy, thoracic surgery, urology, and vascular surgery. The company further oversees critical facilities such as AIRS, Neonatal Intensive Care Units (NICU), endoscopy suites, an institute for robotic surgery, anesthesia services, emergency medicine departments, intensive care units, renal dialysis centers, a specialized rhinoplasty center, and burn units. Additionally, it establishes and manages pharmacies and provides comprehensive laboratory services. Beyond direct healthcare provision, the company is also involved in the wholesale and retail distribution of medical equipment, alongside offering IT equipment maintenance and software-related services. Founded in 1978, the Dr. Soliman Abdel Kader Fakeeh Hospital Company maintains its headquarters in Jeddah, Kingdom of Saudi Arabia.

Company Valuation

Overvalued
2/7

From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, of fair value on EV/EBI

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of 4017.SR is 39 and suggests 7% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.06.2026 22:31

U.S. and Iran to sign agreement on June 14, Strait of Hormuz to reopen - Trump

13.06.2026 16:01

Highlights in small-caps: record IPO in biotech, Wizz Air success, SpaceX effect

13.06.2026 13:01

An investment idea for all times, IPO of the year and how to keep emotions in check in the stock market

13.06.2026 03:02

Microsoft is considering spinning off Xbox into a separate company - The Information

13.06.2026 01:40

Hope for peace with Iran and SpaceX lifted spirits: stocks rose for second straight day

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026